(Press-News.org) Reston, VA—A simple blood draw can provide physicians with valuable information that can determine if peptide receptor radionuclide therapy (PRRT) is likely to be effective in a patient with neuroendocrine cancer. The blood-based biomarker PPQ can predict which patients will respond to PRRT with 96 percent accuracy; changes in another biomarker, NETest, correctly correlate with PRRT response in 90 percent of patients. The study, published in the April issue of The Journal of Nuclear Medicine, opens new possibilities of tailoring radiopharmaceutical treatment to patients.
While biomarkers have been used to predict the outcomes of treatments for breast, prostate, and other cancers, there are currently no objective means to predict the efficacy of radiopharmaceutical therapy for neuroendocrine tumors. “In previous studies our team introduced the blood-based biomarkers PPQ and NETest as a measure for determining whether treatment with PRRT would be successful,” noted Lisa Bodei, MD, PhD, nuclear medicine physician at Memorial Sloan Kettering Cancer Center in New York, New York. “In this new study we sought to validate the role of PPQ and NETest in predicting response and monitoring PRRT.”
Sixty-seven patients with somatostatin receptor-positive gastroenteropancreatic and lung neuroendocrine tumors were included in the study. All patients had metastatic disease and had received prior treatments. Blood samples were collected before each cycle of PRRT and at follow-up. PPQ was scored as either positive (likely to respond) or negative (unlikely to respond), and NETest was measured on a scale of zero to 100, with the upper limit of normality being 20.
Of the 67 patients in the study, 40 were classified as PPQ+, and 39 of them (98 percent) responded to PRRT. Twenty-seven patients were PPQ–, and 25 patients in this group experienced disease progression despite PRRT. The overall predictive accuracy of PPQ was 96 percent.
NETest was elevated in all patients prior to PRRT therapy. For PRRT responders, baseline NETest levels were 67, which decreased by 37 percent after treatment. For non-responders, baseline NETest levels were 44, which increased by 76 percent at follow-up. The NETest biomarker was 90 percent accurate for determining PRRT response.
“The results of this study demonstrate that not all tumors are created equal; some are more prone to respond to PRRT, and some are less susceptible to radiopharmaceutical therapy,” said Bodei. “This is the reason why our research is important: to understand from the start which patients will require an intensified treatment plan and which patients, instead, can benefit from a lighter regimen will tremendously improve their management.”
This study was made available online in November 2022.
The authors of “Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of 177Lu-DOTATATE in Neuroendocrine Tumors” include Lisa Bodei, Richard K. Do, Simone Krebs, and Heiko Schöder, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, and Department of Radiology, Weill Cornell Medical College, New York, New York; Nitya Raj and Diane Reidy-Lagunes, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and Audrey Mauguen, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
DURHAM, N.C. – Engineers at Duke University have produced the world’s first fully recyclable printed electronics that replace the use of chemicals with water in the fabrication process. By bypassing the need for hazardous chemicals, the demonstration points down a path industry could follow to reduce its environmental footprint and human health risks.
The research appeared online Feb. 28 in the journal Nano Letters.
One of the dominant challenges facing any electronics manufacturer is successfully securing several layers of components on ...
There is extensive research on how a fixed-position flap affects lift in the realm of fluid-structure interaction. However, taking the conversation in a new direction, researchers at the University of Illinois Urbana-Champaign conducted a bio-inspired study with a novel twist—variable stiffness—to learn more about how it affects lift.
The researchers wondered if they could model a flap on an airfoil, or wing, with varying stiffnesses over time much like a bird can tense, or stiffen, the musculature and tendons connected to covert feathers.
“We know from previous studies ...
UNIVERSITY PARK, Pa. — Broccoli is known to be beneficial to our health. For example, research has shown that increased consumption of the cruciferous vegetable decreases incidences of cancer and type 2 diabetes. In a recent study, researchers at Penn State found that broccoli contains certain molecules that bind to a receptor within mice and help to protect the lining of the small intestine, thereby inhibiting the development of disease. The findings lend support to the idea that broccoli truly is a ‘superfood.’
“We ...
A rapid spike in cases of a potentially deadly, drug-resistant fungus has concerned public health officials across the nation. But a team of Southern Nevada researchers hope their new study applying wastewater surveillance can help health officials get a step ahead of this emerging global public health threat.
The Pathogen Problem
Candida auris is a fungus that can cause serious infections, particularly in patients who are immunocompromised, have pre-existing health conditions, are in long-term healthcare settings, or are undergoing treatment with invasive medical devices such as a catheter. Infection prevention ...
Giving pregnant women routine third trimester ultrasound scans could reduce rates of undetected breech pregnancy by 71%, enabling better care before and during labor and improved outcomes for newborns
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004192
Article Title: Impact of point-of-care ultrasound and routine third trimester ultrasound on undiagnosed breech presentation and perinatal outcomes: An observational multicentre cohort study
Author Countries: United Kingdom, Turkey
Funding: The author(s) received no specific funding for this work. END ...
An implant that delivers electrical stimulation to a select group of spinal neurons can treat dangerously low blood pressure in people with spinal cord injuries, addressing an often “invisible” consequence of paralysis.
For his work in developing this treatment, called the neuroprosthetic baroreflex, Jordan W. Squair is the winner of the 2023 BioInnovation Institute & Science Prize for Innovation. The prize seeks to reward scientists who deliver research at the intersection of the life sciences and entrepreneurship.
“Dr. Squair’s prize-winning research on epidural electrical stimulation restores blood pressure control in patients ...
In an editorial, Maria Van Kerkhove – who serves as the technical lead for the COVID-19 response at the World Health Organization (WHO) – outlines how earlier this month (March 2023), WHO learned that scientists in China possessed data on viral samples from Wuhan that had been gathered in January 2020. “These should have been shared immediately—not 3 years later,” she writes. “The lack of data disclosure is simply inexcusable.” WHO continues to call on China and all countries to share any data on the origins of SARS-CoV-2 immediately. “China has advanced technical capabilities,” Van ...
Male yellow crazy ants (Anoplolepis gracilipes) are chimeras of two separate genetic lineages, researchers report in a study that reveals a unique mode of reproduction in this species – one previously unknown to science. While most multicellular organisms develop from a single-cell zygote into a collection of genetically identical cells – a hallmark of biological inheritance – the new findings show that yellow crazy ants deviate from this expectation. According to the study, all male yellow crazy ants are instead composed ...
First ever study looking at disease risks of wild meat activities in rural communities.
Nearly 70% of rural respondents at Kenya-Tanzania border said that COVID-19 did not impact their levels of wild meat consumption, with some even reporting increased consumption.
Ungulates were found to be the most consumed species, followed by birds, rodents and shrews.
Governments need to focus on better controlling zoonotic disease transmission risks through community engagements on behavior change interventions, improving hygiene and standards of informal markets, supporting wildlife conservation ...
A class of polyesters considered a promising alternative to common plastics, were it not for limitations like brittleness and thermal instability, have now been made more mechanically tough and thermally stable. Researchers replaced the reactive hydrogens in the monomer of these materials – polyhydroxyalkanoate (PHA) plastics – and found it enhanced PHA thermal and mechanical properties and enabled closed-loop chemical recyclability. The new approach could provide a route for increased use of sustainable PHA plastics. ...
